Scientific Reports (Dec 2022)

Genetic epidemiology of inherited retinal diseases in a large patient cohort followed at a single center in Italy

  • Marianthi Karali,
  • Francesco Testa,
  • Valentina Di Iorio,
  • Annalaura Torella,
  • Roberta Zeuli,
  • Margherita Scarpato,
  • Francesca Romano,
  • Maria Elena Onore,
  • Mariateresa Pizzo,
  • Paolo Melillo,
  • Raffaella Brunetti-Pierri,
  • Ilaria Passerini,
  • Elisabetta Pelo,
  • Frans P. M. Cremers,
  • Gabriella Esposito,
  • Vincenzo Nigro,
  • Francesca Simonelli,
  • Sandro Banfi

DOI
https://doi.org/10.1038/s41598-022-24636-1
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 15

Abstract

Read online

Abstract Inherited retinal diseases (IRDs) are the leading cause of vision loss in the working-age population. We performed a retrospective epidemiological study to determine the genetic basis of IRDs in a large Italian cohort (n = 2790) followed at a single referral center. We provided, mainly by next generation sequencing, potentially conclusive molecular diagnosis for 2036 patients (from 1683 unrelated families). We identified a total of 1319 causative sequence variations in 132 genes, including 353 novel variants, and 866 possibly actionable genotypes for therapeutic approaches. ABCA4 was the most frequently mutated gene (n = 535; 26.3% of solved cases), followed by USH2A (n = 228; 11.2%) and RPGR (n = 102; 5.01%). The other 129 genes had a lower contribution to IRD pathogenesis (e.g. CHM 3.5%, RHO 3.5%; MYO7A 3.4%; CRB1 2.7%; RPE65 2%, RP1 1.8%; GUCY2D 1.7%). Seventy-eight genes were mutated in five patients or less. Mitochondrial DNA variants were responsible for 2.1% of cases. Our analysis confirms the complex genetic etiology of IRDs and reveals the high prevalence of ABCA4 and USH2A mutations. This study also uncovers genetic associations with a spectrum of clinical subgroups and highlights a valuable number of cases potentially eligible for clinical trials and, ultimately, for molecular therapies.